BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10522486)

  • 1. [Immunologic reactions in transplantation].
    Vartdal F; Thorsby E
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3167-70. PubMed ID: 10522486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in understanding and exploiting the immune response in solid organ and hemopoietic stem cell transplantation.
    Christiansen FT; Velardi A
    Curr Opin Immunol; 2009 Oct; 21(5):522-4. PubMed ID: 19782548
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing role of natural killer cells in solid organ rejection and tolerance.
    Kitchens WH; Uehara S; Chase CM; Colvin RB; Russell PS; Madsen JC
    Transplantation; 2006 Mar; 81(6):811-7. PubMed ID: 16570001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of mismatched human fetal liver cells: tolerance induction via clonal deletion and clonal anergy.
    Touraine JL; Bacchetta R; Yssel H; de Vries J; Roncarolo MG
    Transplant Proc; 1995 Feb; 27(1):622-4. PubMed ID: 7879123
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology of liver allografts and xenografts in nonhuman primates.
    Donato MF; Arosio E; Berti E; Gatti S; Piazzini A; Colledan M; Rossi G; Fassati LR; Galmarini D; Gridelli B
    Transplant Proc; 1993 Feb; 25(1 Pt 2):850-5. PubMed ID: 8442246
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation recent advances in transplantation immunology.
    Gluckman E
    Curr Opin Immunol; 2006 Oct; 18(5):556-8. PubMed ID: 16893635
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
    Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
    Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
    Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.